Includes the indicators: Human Resources in R&D; Researchers in R&D; R&D Investment; R&D Investment by Companies; Scientific Publications in Medical and Health Sciences; Participation in European Funding Programmes; Clinical Trial Authorization Requests; Authorized Clinical Trials.
- R&D Expenditure in the R&D field “Medical and Health Sciences”
Source: Directorate-General for Education and Science Statistics (DGEEC)
Values are presented in millions of euros.
For more information, consult the DGEEC methodological note here.
- R&D Expenditure – Companies in the field “Medical and Health Sciences”
Source: Directorate-General for Education and Science Statistics (DGEEC)
Values are presented in millions of euros.
For more information, consult the DGEEC methodological note here.
- Human Resources in R&D Activities
Refers to the total number in FTEs, which corresponds to the number of hours that a full-time employee (allocated at 100%) works for an entity.
Source: Directorate-General for Education and Science Statistics (DGEEC)
For more information, consult the DGEEC methodological note here.
Refers to the total number of Researchers in the R&D field “Medical and Health Sciences”. The total number is presented in FTEs, which corresponds to the number of hours that a full-time employee (allocated at 100%) works for an entity.
Source: Directorate-General for Education and Science Statistics (DGEEC).
For more information, consult the DGEEC methodological note here.
- Scientific Publications in Medical and Health Sciences
Refers to the total number of scientific publications whose scientific field (FORD – Fields of Research and Development from OECD) is “Medical and Health Sciences”.
Source: Directorate-General for Education and Science Statistics (DGEEC).
For more information, consult the DGEEC methodological note here.
Refers to the total number of Portuguese patents granted via the European Patent Office (EPO) in the fields “Medical Technology”, “Biotechnology”, and “Pharmaceuticals”.
Source: EPO.
For more information, consult the EPO methodological note here.
- Participation in FP7/H2020/Horizon Europe Programmes
Refers to the annual success rate, calculated as the ratio between the number of projects approved for funding and the number of eligible proposals submitted with Portuguese partners.
Data between 2009-2015 – Source: Framework Programme Promotion Office (GPPQ)
Data between 2021-2024 – Source: PERIN (Portugal in Europe Research and Innovation Network)
- Clinical Trial Authorization Requests
Source: Infarmed.
For more information, consult the methodological note here.
- Authorized Clinical Trials
Source: Infarmed.
For more information, consult the methodological note here.